1. Rol' sistemy matriksnykh metalloproteinaz v progressirovanii pervichnoj otkrytougol'noj glaukomy. / A. S. Khokhlova, E. V. Markelova, N. V. Filina, O. V. Ovchinnikova, T. G. Vaeva, A. A. Kabieva // Tikhookeanskij meditsinskij zhurnal.– 2017.– № 2.– S. 32–34.– doi: 10.17238/PmJ1609–1175.2017.2.32–34 [The role of matrix metalloproteinase system in the primary open angle glaucoma patient. / A. S. Khokhlova, E. V. Markelova, N. V. Filina, O. V. Ovchinnikova, T. G. Vaeva, A. A. Kabieva // Pacific Medical Journal. –2017. – N. 2 – p. 32–34.]
2. Blockade of P2X4 Receptors Inhibits Neuropathic Pain-Related Behavior by Preventing MMP-9 Activation and, Consequently, Pronociceptive Interleukin Release in a Rat Model. / A. M. Jurga, A. Piotrowska, W. Makuch, B. Przewlocka, J. Mika // Front Pharmacol. – 2017. – Vol. 8. – I. 48. – doi: 10.3389/fphar.2017.00048.
3. Lakhan S. E. Matrix Metalloproteinases in Neuropathic Pain and Migraine: Friends, Enemies, and Therapeutic Targets. / S. E. Lakhan, M. Avramut. // Pain Res Treat. – 2012. – Vol. 2012. – I. 952906. – doi: 10.1155/2012/952906.
4. The role of microglia in the pathobiology of neuropathic pain development: what do we know? / H. Zhao, A. Alam, Q. Chen, M. A. Eusman, A. Pal, S. Eguchi, L. Wu, D. Ma. // Br J Anaesth. – 2017. – Vol. 118. – P. 504–516. – doi: 10.1093/bja/aex006.
5. Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection. / M. M. Lee, B-J. Yoon, K. Osiewicz, M. Preston, B. Bundy, A.M. van Heeckeren, Z. Werb, P. D. Soloway. // Infect Immun. – 2005. – Vol. 73. – P. 661–665. – doi: 10.1128/IAI.73.1.661–665.2005.